Company intelligence / Profile preview

ByHeart

New York City, New York, United Statesbyheart.com ↗

Ownership: Private
Employees: ~275
Development stage: Commercial

Overview

ByHeart has developed a clinically tested infant formula with a patented protein blend designed to closely mimic human breast milk. Their clinical trial was the largest by a new infant formula brand in over 25 years and included a breast milk reference arm. The product is Clean Label Project Certified and has received the highest "Purity Award." The company owns its end-to-end manufacturing process, ensuring rigorous quality control.

Therapeutic areas: Metabolic DisordersWomen's Health
Modalities: Protein blend (patented, closest-to-human-milk protein blend)Nutritional formula (Infant formula)
Industry: Food & Nutrition

Drug pipeline

1 asset

Whole Nutrition Infant Formula

Commercial

Indications: Infant nutrition

Partnerships

Walmart, Wegmans, Whole Foods Market for distribution contracts

Beyond the preview

Go deeper on ByHeart.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ByHeart.

Explore the full profile